America's Most Admired Lawbreaker: Chapter 8, "Firing Blanks, Hunting for Smoking Guns"
A Weak First Case On December 14, 2006, Stephen Sheller filed his first case against Johnson & Johnson. The client was a New Jersey boy who had taken Risperdal beginning in 2001. When he had met the boy and his mother, Sheller thought the case would be about diabetes and weight gain. But then she and her son became traumatized by his growing breasts, and in August 2004, he had radical surgery to remove them. Still, the suit focused on diabetes, and the complaint Sheller wrote
America's Most Admired Lawbreaker: Chapter 3, Sales Over Science
Putting The Risks in 'Tiny Font' By the beginning of 1999, Johnson & Johnson had expanded the ElderCare unit to 136 salespeople from 83, and the materials they were using to pitch doctors had caught the FDA’s eye. On January 5, Lisa Stockbridge of the FDA’s Division of Drug Marketing, Advertising and Communications wrote to Janssen’s director of regulatory affairs complaining that “presentations that focus on this population are misleading in that they imply that the drug has